Search Within

Christina Bello

Formats
  1. Meeting Abstract (11)
  2. Journal Article (4)
Groups
  1. Bone Marrow Transplant (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. Hematologic Malignancies, Division of (15)
  5. Survivorship Research (15)
  6. Myeloma (13)

More Groups

People
  1. Heather Landau (15)
  2. Hani Hassoun (13)
  3. Elizabeth Hoover (9)
  4. Elyn Stubblefield (9)
  5. Sergio Giralt (7)
  6. Joanne Chou (5)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2014 (1)
  4. 2013 (3)
  5. 2012 (4)
  6. 2011 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (5)
  2. Blood (5)
  3. Amyloid (2)
  4. Leukemia (2)
  5. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (5)
  3. Taylor & Francis Group (3)
  4. Nature Publishing Group (2)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis
    Meeting Abstract

    Landau, H.; Hassoun, H.; Hoffman, J. E.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P. S.; Comenzo, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Journal Article

    Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
    Amyloid (2011)

    Fulltext@MSK | Save
  • Maintained hematologic and organ responses at two years following stem cell transplant in systemic light-chain amyloidosis (AL) using short-course bortezomib and dexamethasone consolidation therapy
    Meeting Abstract

    Landau, H.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Lesokhin, A.; Lendvai, N.; Cohen, A.; Nimer, S.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Meeting Abstract

    Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Jia, X.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
    Amyloid (2010)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; more...
    Blood (2009)

    Fulltext@MSK | Save